Naringin acts as a TRPV1 antagonist to attenuate UVB-induced senescence and damage in HaCaT cells

Chem Biol Drug Des. 2024 Jan;103(1):e14390. doi: 10.1111/cbdd.14390. Epub 2023 Nov 9.

Abstract

This study aimed to explore the mechanism of naringin (Nar) in alleviating ultraviolet B (UVB)-induced HaCaT cell senescence and damage. Human keratinocytes (HaCaT cells) were divided into control, UVB, UVB + Nar, UVB + Cap, and UVB + Nar + Cap groups. Analysis was performed using the MTT assay to assess cell viability, flow cytometry to measure the apoptosis level, SA-β-Gal staining to observe cellular senescence, and Western blot to assess protein levels of TRPV1, p16, p53, p21, matrix metalloproteinase (MMP)-1, and MMP-9. Both UVB irradiation and capsaicin (Cap) treatment upregulated the expression of TRPV1 in HaCaT cells, inhibited cell proliferation, promoted apoptosis, and increased the expression of p16, p53, p21, MMP-1, and MMP-9. Nar treatment reversed the above effects via inhibition of TRPV1 expression, thereby relieving senescence and cell damage induced by UVB irradiation. Taken together, these findings suggest that Nar can reduce UVB-induced senescence and damage in HaCaT cells by acting as an antagonist of TRPV1.

Keywords: human keratinocyte; naringin (Nar); transient receptor potential vanilloid 1 (TRPV1) antagonist; ultraviolet B (UVB)-induced senescence and damage.

MeSH terms

  • Apoptosis
  • Flavanones*
  • HaCaT Cells*
  • Humans
  • Keratinocytes / metabolism
  • Keratinocytes / radiation effects
  • Matrix Metalloproteinase 9* / metabolism
  • TRPV Cation Channels / metabolism
  • TRPV Cation Channels / pharmacology
  • Tumor Suppressor Protein p53 / metabolism
  • Ultraviolet Rays

Substances

  • naringin
  • Matrix Metalloproteinase 9
  • Tumor Suppressor Protein p53
  • TRPV1 protein, human
  • TRPV Cation Channels
  • Flavanones